# Diamedica (DMAC) — Earnings

DMAC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/dmac/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.19 |
| EPS estimate | −$0.20 |
| EPS surprise | +5.43% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 10, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1401040/000143774926026792/dmtp20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/06644d9d-99b1-92c5-7ded-24b87bf7e86e.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 10, 2026 | −$0.20 | −$0.19 | 5.43% | — | — |
| Q1 2026 | May 6, 2026 | −$0.19 | −$0.19 | -2.37% | — | — |
| Q4 2025 | Mar 30, 2026 | −$0.18 | −$0.17 | 5.56% | — | — |
| Q3 2025 | Nov 12, 2025 | −$0.16 | −$0.17 | -6.25% | — | — |
| Q2 2025 | Aug 12, 2025 | −$0.19 | −$0.18 | 5.26% | — | — |
| Q1 2025 | May 13, 2025 | −$0.18 | −$0.18 | 0.00% | — | — |
| Q4 2024 | Mar 17, 2025 | −$0.17 | −$0.18 | -4.35% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.16 | −$0.15 | 3.23% | — | — |
| Q2 2024 | Aug 7, 2024 | −$0.16 | −$0.13 | 17.04% | — | — |
| Q1 2024 | May 8, 2024 | −$0.16 | −$0.14 | 10.66% | — | — |
| Q4 2023 | Mar 19, 2024 | −$0.14 | −$0.12 | 14.29% | — | — |
| Q3 2023 | Nov 13, 2023 | −$0.13 | −$0.12 | 5.29% | — | — |
| Q2 2023 | Aug 14, 2023 | −$0.18 | −$0.16 | 9.45% | — | — |
| Q1 2023 | May 15, 2023 | −$0.16 | −$0.20 | -25.00% | — | — |
| Q4 2022 | Mar 28, 2023 | −$0.14 | −$0.14 | 0.00% | — | — |
| Q3 2022 | Nov 9, 2022 | −$0.15 | −$0.12 | 18.64% | — | — |
| Q2 2022 | Aug 10, 2022 | −$0.18 | −$0.13 | 27.78% | — | — |
| Q1 2022 | May 4, 2022 | −$0.20 | −$0.13 | 35.00% | — | — |
| Q4 2021 | Mar 14, 2022 | −$0.18 | −$0.11 | 38.03% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.23 | −$0.18 | 21.05% | — | — |

## Frequently Asked Questions

### When did Diamedica (DMAC) last report earnings?

Diamedica last reported on Aug 10, 2026, covering fiscal Q2 2026.

### Did DMAC beat earnings estimates?

Yes. Diamedica reported EPS of −$0.19 for Q2 2026 against a −$0.20 estimate — a 5.43% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).